Care For Your Liver, Every Day.
Ursodeoxycholic Acid Suspension
Support. Protect. Restore. 🌱
Formulations in this Promotion
Explore DCGI-approved formulations and commercial batch specifications ready for immediate third-party manufacturing at Saar Biotech.
A hepatoprotective suspension containing Ursodeoxycholic Acid 125mg/5ml — manufactured at our WHO-GMP Baddi facility for liver and biliary …
- Ursodeoxycholic Acid IP 125 mg
- Flavoured Suspension Base q.s.
Linked Manufacturing Capabilities
Explore related manufacturing divisions, dosage forms, and technical resources to support your product launch.
When it comes to specialized hepatology products, stability and precise dosing are paramount. Saar Biotech provides dedicated third-party manufacturing for Ursodeoxycholic Acid 125 mg Suspension, a critical formulation designed to support, protect, and restore liver health.
Our liquid manufacturing section is equipped with advanced homogenization technology to ensure that the active ingredient remains uniformly suspended, delivering exactly 125mg per dose. Whether you are launching a new gastroenterology portfolio or expanding your existing liver health range, our WHO-GMP certified facility in Baddi ensures a market-ready, high-quality product.
Frequently Asked Questions
Common B2B manufacturing and campaign questions about Ursodeoxycholic Acid Suspension.
Connect directly with our technical team in Baddi for formulation batch planning and custom MOQs.
More Promotions
Explore other active manufacturing promotions and formulations.
Ready to start a manufacturing partnership?
Share your approved composition or product category, dosage form, packing requirement, quantity, and timeline. The Saar team will respond with practical next steps.